Bone mineral density of children and adolescents with congenital hypothyroidism;Densidade mineral óssea de crianças e adolescentes com hipotireoidismo congênito

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 7, 2007, Pages 1084-1092

  Demartini, Adriane De André Cardoso ^a,b   Kulak, Carolina A M ^a   Borba, Victoria C ^a   Cat, Mônica N L ^a   Dondoni, Roberta S ^a   Sandrini, Romolo ^a   Nesi França, Suzana ^a   De Lacerda Filho, Luiz ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NONE   (Brazil)

Author keywords

Bone mineral content; Bone mineral density; Congenital hypothyroidism; Dual energy X ray absorptiometry (DXA)

Indexed keywords

EID: 38149138166     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000700010     Document Type: Article

References (43)

1. Kopp P. Perspective: genetic defects in the etiology of congenital hypothyroidism. Endocrinology 2002;143:2019-24.
2. Brown RS, Demmer LA. Editorial: the etiology of thyroid dysgenesis - still an enigma after all these years. J Clin Endocrinol Metab 2002;87:4069-71.
3. Harvey CB, O'Shea PJ, Scott AJ, Robson H, Siebler T, Shalet SM, et al. Molecular mechanisms of thyroid hormone effects on bone growth and function. Mol Genet Metab 2002;75:17-30.
4. Basset JHD, Williams GR. The molecular actions of thyroid hormone in bone. Trends Endocrinol Metab 2003;14:356-64.
5. Rizzoli R, Poser J, Bürgi U. Nuclear thyroid hormone receptors in cultured bone cells. Metabolism 1986;35:71-4.
6. Robson H, Siebler T, Stevens DA, Shalet SM, Williams GR. Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. Endocrinology 2000;141:3887-97.
7. Lakatos P, Foldes J, Horvath C, Kiss L, Tatrai A, Takacs I, et al. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab 1997;82:78-81.
8. Carey DE, Jones KL, Parthemore JG, Deftos LJ. Calcitonin secretion in congenital nongoitrous cretinism. J Clin Invest 1980;65:892-5.
9. Zamboni G, Avanzini S, Giavarina D, Tato L. Monomeric calcitonin secretion in infants with congenital hypothyroidism. Acta Paediatr Scand 1989;78:885-8.
10. Demeester-Mirkine N, Bergmann P, Body J-J, Corvilain J. Calcitonin and bone mass status in congenital hypothyroidism. Calcif Tissue Int 1990;46:222-6.
11. Body JJ, Chanoine JP, Dumon JC, Delange F. Circulating calcitonin levels in healthy children and subjects with congenital hypothyroidism from birth to adolescence. J Clin Endocrinol Metab 1993;77:565-7.
12. Daripa M, Paula FJD, Rufino ACB, Foss MC. Impact of congenital calcitonin deficiency due to dysgenetic hypothyroidism on bone mineral density. Braz J Med Biol Res 2004;37:61-8.
13. Kooh SW, Brnjac L, Ehrlich RM, Qureshi R, Krishnan S. Bone mass in children with congenital hypothyroidism treated with thyroxine since birth. J Pediatr Endocrinol Metab 1996;9:59-62.
14. Léger J, Ruiz JC, Guibourdenche J, Kindermans C, Garabedian M, Czernichow P. Bone mineral density and metabolism in children with congenital hypothyroidism after prolonged L-thyroxine therapy. Acta Paediatr 1997;86:704-10.
15. Pitukcheewanont P, Safani D, Gilsanz V, Klein M, Chongpison Y, Costin G. Quantitative computed tomography measurements of bone mineral density in prepubertal children with congenital hypothyroidism treated with L-thyroxine. J Pediatr Endocrinol Metab 2004;17:889-93.
16. Salerno S, Lettiero T, Esposito-del Puente A, Esposito V, Capalbo D, Carpinelli A, et al. Effect of long-term L-thyroxine treatment on bone mineral density in young adults with congenital hypothyroidism. Eur J Endocrinol 2004;151:689-94.
17. National Center for Health Statistics (NCHS). Clinical growth charts 2000. Disponível em: 〈http://www.cdc.gov/ nchs/about/major/ nhanes/growthcharts/clinical_charts.htm〉.
18. nd ed. Oxford: Blackwell, 1962.
19. Prader A. Testicular size: assessment and clinical importance. Triangle 1966;7:240-3.
20. Thériault D. BMD Patient intake questionnaire 2004. Disponível em: 〈http://www.iscd.org/visitors/resources/ BMDQuestionaire.doc〉.
21. Institute of Medicine, The Food and Nutrition Board. Dietary references intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academies Press, 1997.
22. nd ed. Stanford: Stanford University Press, 1959.
23. Baran DT. Editorial: detrimental skeletal effects of thyrotropin suppressive doses of thyroxine: fact or fantasy? J Clin Endocrinol Metab 1994;78:816-7.
24. National Institutes of Health. Osteoporosis prevention, diagnosis and therapy: Consensus Conference. JAMA 2001;285:785-95.
25. Lakatos P. Thyroid hormones: beneficial or deleterious for bone? Calcif Tissue Int 2003;73:205-9.
26. Abe E, Marians RC, Yu W, Xue-Bin W, Ando T, Li Y, et al. TSH is a negative regulator of skeletal remodeling. Cell 2003;115:151-62.
27. Hase H, Ando T, Eldeiry L, Brebene A, Yuanzhen P, Liu L, et al. TNFα mediates the skeletal effects of thyroid-stimulating hormone. Proc Natl Acad Sci U S A 2006;103:12849-54 (Disponível online em: 〈http://www.pnas.org/cgi/doi/10.1073/pnas.0600427103〉).
28. Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA 1995;273:808-12.
29. BRASIL. Ministério da Saúde. Portaria no 848, 2002. Disponível em: 〈http://dtr2001.saude.gov.br/sas/PORTARIAS/PORT2002/ PT-848.htm〉.
30. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 1996;81:4278-89.
31. Glastre G, Braillon P, David L, Cochat P, Meunier PJ, Delmas PD. Measurement of bone mineral content of lumbar spine by dual energy X-ray absorptiometry in normal children: correlations with growth parameters. J Clin Endocrinol Metab 1990;70:1330-3.
32. st ed. Amsterdam: Elsevier, 1996. pp. 93-102.
33. Fonseca ASM, Szejnfeld VL, Terreri MT, Goldenberg J, Ferraz MB, Hilário MOE. Bone mineral density of the lumbar spine of Brazilian children and adolescents aged 6 to 14 years. Braz J Med Biol Res 2001;34:347-52.
34. Bonjour JP, Theintz G, Buchs B, Slosman D, Rizzoli R. Critical years and stage of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991;73:555-63.
35. Ellis KJ, Shypailo RJ, Pratt JA, Pond WG. Accuracy of dual-energy x-ray absorptiometry for body-composition measurements in children. Am J Clin Nutr 1994;60:660-5.
36. Molgaard C, Thomsen BL, Prentice A, Cole TJ, Michaelsen KF. Whole body bone mineral content in healthy children and adolescents. Arch Dis Child 1997;76:9-15.
37. Frost HM. Obesity, and bone strength and "mass": a tutorial based on insights from a new paradigm. Bone 1997;21:211-4.
38. a ed. São Paulo: Sarvier, 2002. pp. 354-62.
39. Boot AM, Ridder MAJ, Pols HAP, Krenning EP, Keizer-Schrama SPFM. Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab 1997;82:57-62.
40. Slemenda CW, Reister TK, Hui SL, Miller JZ, Christian JC, Johnston Jr. CC. Influences on skeletal mineralization in children and adolescents: evidence for varying effects of sexual maturation and physical activity. J Pediatr 1994;125:201-7.
41. Soyka LA, Fairfield WP, Klibanski A. Hormonal determinants and disorders of peak bone mass in children. J Clin Endocrinol Metab 2000;85:3951-62.
42. Chan GM. Dietary calcium and bone mineral status of children and adolescents. Am J Dis Child 1991;145:631-4.
43. Bonjour JP, Carrie AL, Ferrari S, Clavien H, Slosman D, Theintz G, et al. Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest 1997;9:1287-94.